Elsevier

Neuroscience Research

Volume 35, Issue 2, November 1999, Pages 77-83
Neuroscience Research

Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice

https://doi.org/10.1016/S0168-0102(99)00070-XGet rights and content

Abstract

Serotonin (5-HT) is pruritogenic in humans and suggested to be involved in some pruritic diseases. Our experiments were carried out to determine whether an intradermal injection of 5-HT would elicit itch-associated response in mice and to elucidate the 5-HT receptor subtypes involved in this 5-HT action. 5-HT (14.1–235 nmol site−1) injected intradermally into the rostral back elicited scratching of the injected site, with bell-shaped dose-response relationship. The scratching induced by 5-HT (100 nmol site−1, peak effective dose) was suppressed by capsaicin (repeated administration) and the opioid antagonist naloxone, features being similar to human itching. Scratching was also elicited by the 5-HT2 receptor agonist α-methylserotonin, but not by the 5-HT1A receptor agonist R(+)-8-hydroxy-N,N-dipropyl-2-aminotetralin nor the 5-HT3 receptor agonists 2-methylserotonin and 1-phenylbiganide. Scratching induced by 5-HT and α-methylserotonin was inhibited by peroral pretreatment with 5-HT1/2 receptor antagonists methysergide and cyproheptadine. 5-HT-induced scratching was also inhibited by intradermal injection of methysergide. Peroral pretreatment with 5-HT3 receptor antagonists ondansetron and 3-tropanyl-3, 5-dichrobenzoate did not significantly suppress 5-HT-induced scratching. The results suggest that scratching induced by intradermal injection of 5-HT is itch-associated response. The 5-HT action may be mediated at least partly by cutaneous 5-HT2 receptors.

Introduction

Itch is a sensation that is localized to the superficial layers of the skin (Shelley and Arthur, 1957, Keele and Armstrong, 1964) and associated with a desire to scratch the offending area. Itch is the main symptom of cutaneous diseases, such as atopic dermatitis and contact dermatitis, and accompanying several systemic diseases, such as polycythemia vera, chronic renal failure and cholestasis. However, its pathophysiological mechanisms are not clear. When applied to the mouse skin, pruritogenic agents, such as compound 48/80 and substance P, elicit scratching of the treated skin, while algesiogenic agents, such as capsaicin and formalin, are without apparent behavioral effects (Kuraishi et al., 1995). Thus, compound 48/80- and substance P-induced scratching may not be due to pain. Scratching induced by substance P has features similar to human itching; for example, the opioid antagonist naloxone inhibits substance P-induced scratching in mice (Andoh et al., 1998) and an itch sensation induced by histamine in human subjects (Bernstein et al., 1982). On the other hand, naloxone enhances pain behavioral responses in rodents (Jacob and Ramabadran, 1978, Sugimoto et al., 1986). These findings taken together suggest that substance P-induced scratching is an itch-associated response.

Although histamine is a classical itch mediator in humans (Armstrong et al., 1953, Wahlgren and Ekblom, 1991), it does not elicit the itch-associated response in mice (Kuraishi et al., 1995), suggesting that this amine is not a primary itch mediator in mice. Serotonin (5-HT) produces an itch sensation when applied to the human skin (Fjellner and Hägermark, 1979, Weisshaar et al., 1997) and has been suggested to be involved in itch of pruritic diseases, such as polycythemia vera (Fitzsimons et al., 1981) and cholestasis (Schwörer et al., 1995). To investigate pruritogenic activity of 5-HT in animals, we examined whether an intradermal (ID) injection of 5-HT would elicit itch-associated behaviors in mice and determined the 5-HT receptor subtypes involved in this response.

Section snippets

Materials

Serotonin hydrochloride, capsaicin, naloxone hydrochloride and cyproheptadine hydrochloride were purchased from Sigma (St. Louis, MO) and histamine was from Wako Pure Chemical (Osaka, Japan). 1-Phenylbiganide, 2-methylserotonin maleate, R(+)-8-hydroxy-N,N-dipropyl-2-aminotetralin hydrobromide (8-OH-DPAT), α-methylserotonin maleate, methysergide maleate and 3-tropanyl-3, 5-dichrobenzoate (MDL-72222) were from Research Biochemical International (Massachusetts, USA). Ondansetron was a gift from

Scratching after 5-HT and histamine

When injected ID into the rostral back, 5-HT elicited scratching of the injected site and the surrounding region by the hind paws. Fig. 1 shows an example of scratching responses to 5-HT (141 nmol site−1=30 μg site−1). Although 5-HT at a dose of 1.41 nmol site−1 was without apparent effect, 5-HT (14.1–141 nmol site−1) produced a dose-dependent increase in scratching (Fig. 2). The effect of higher dose of 235 nmol site−1 was significant but much less than that of 141 nmol site−1. The median of

Discussion

We demonstrated that an ID injection of 5-HT, but not histamine, into the rostral back of the mouse elicited scratching of the injected site and surrounding skin by the hind paws. Such 5-HT injection did not elicit the scratching of the face and ID injection of this amine into the caudal back, a region the mouse can not scratch, did not induce the scratching of the rostral back. These results suggest that ID injection of 5-HT induced scratching through local skin stimulation and that this

Acknowledgements

This work was supported in part by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, sports and Culture of Japan.

References (42)

  • P.A. Pierce et al.

    5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study

    Neuroscience

    (1996)
  • H. Schwörer et al.

    Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron

    Pain

    (1995)
  • M. Sugimoto et al.

    Enhancement of a nociceptive reaction by opioid antagonists in mice

    Neuropharmacology

    (1986)
  • S. Todorovic et al.

    5-HT2 and 5-HT3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons

    Brain Res.

    (1990)
  • D.A. Thomas et al.

    Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching

    Brain Res.

    (1995)
  • D.A. Thomas et al.

    Effects of central administration of opioids on facial scratching in monkeys

    Brain Res.

    (1992)
  • J. Wallengren

    Treatment of notalgia paresthetica with topical capsaicin

    J. Am. Acad. Dermatol.

    (1991)
  • T. Andoh et al.

    Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice

    J. Pharmacol. Exp. Ther.

    (1998)
  • D. Armstrong et al.

    Observation on chemical excitants of cutaneous pain in man

    J. Physiol.

    (1953)
  • N.V. Bergasa et al.

    Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

    Ann. Intern. Med.

    (1995)
  • I.M. Crighton et al.

    Ondansetron for the treatment of pruritus after spinal opioids

    Anaesthesia

    (1996)
  • Cited by (174)

    • The role of PTEN in primary sensory neurons in processing itch and thermal information in mice

      2022, Cell Reports
      Citation Excerpt :

      For acute itch sensation assessment, the nape regions of PTEN CKO, TRPV1: PTEN dCKO and control mice were carefully shaved 1 day prior to tests. Intradermal injections of 50 μL PBS-dissolved pruritogens were administered as follows: histamine (10 μg/μL; Sigma, H7125), compound 48/80 (2 μg/μL; Sigma, C2313), chloroquine (4 μg/μL; Sigma, C6628), 5-HT (0.4 μg/μL; Sigma, H7752) and the PAR2 agonist SLIGRL-NH2 (2 μg/μL; Sigma, S9317) (Yamaguchi et al., 1999; Zhang et al., 2014). Scratching behavior was quantified by counting the number of scratches with hind limbs toward the shaved skin within 30 min after administration of pruritogens by a trained observer who was blind to the experimental design.

    • Role of TRP ion channels in pruritus

      2022, Neuroscience Letters
    View all citing articles on Scopus
    View full text